Study co-author
				Stephen Tsang, M.D., Ph.D., associate professor of 
				ophthalmology, pathology, and cell biology at CUMC, Columbia's 
				Institute of Genomic Medicine, and the Institute of Human 
				Nutrition, said:
				
					
					"We feel 
					it's critical that the scientific community consider the 
					potential hazards of all off-target mutations caused by CRISPR, 
					including single-nucleotide mutations and mutations in 
					noncoding regions of the genome." [2]
				
				
				CRISPR alters 
				specific DNA sequences, but fails to correct the side effects 
				that occur as a result.
				 
				
				There are 
				currently 2 clinical trials involving humans underway in China, 
				and a U.S. trial is slated to begin sometime next year. As many 
				as 20 trials are in the works. 
				 
				
				One of the 
				trials is aimed at preventing cervical cancers by using CRISPR 
				to target and destroy the genes of the human papillomavirus (HPV) 
				that cause tumors. [1] [3]
				 
				
				Here is a video 
				talking a little bit about CRISPR.
				
					
  
					
					 
					 
					 
					
					Scientists 
					identify areas likely to be affected by off-target DNA 
					mutations with the assistance of predictive computer 
					
					algorithms. 
					 
					
					Refinements 
					to the technology suggested that in those trials off-target 
					effects would be few. But nobody knows for certain how many 
					side effects will result, or how serious they will be, and 
					many experts are convinced the technology is simply not safe 
					for use in humans at this point in time. [2]
					 
					
					
					Alexander Bassuk, M.D., Ph.D., the study's co-author and 
					professor of pediatrics at the University of Iowa, said:
					
						
						"These 
						predictive algorithms seem to do a good job when CRISPR 
						is performed in cells or tissues in a dish, but 
						whole-genome sequencing (WGS) has not been employed to 
						look for all off-target effects in living animals."
					
					
					In the 
					experiment in mice, researchers learned that success in the 
					lab doesn't always translate into success in the real world. 
					The team looked at mice that they had previously corrected a 
					blindness-associated gene in and sequenced their entire 
					genome to find changes.
					 
					
					Though the 
					mice's vision was restored, 2 of them were left with over 
					1,500 unintended mutations, and more than 100 deletions and 
					insertions of genes the researchers never intended to touch.
					
					 
					
					What's 
					more, the computer algorithm failed to predict any of 
					them. [1]
					 
					
					Outwardly, 
					the mice didn't look any different or develop any 
					superpowers. But how the mutations will impact the mice in 
					the future, or in subtle ways, remains an unanswered 
					question for now. 
					 
					
					The vast 
					majority of genetic mutations are not good. They're exactly 
					what CRISRP is intended to treat.
					 
					
					
					One scientist warned in January 2017 that
					
					gene-editing has the potential to "ruin human evolution." 
					Obviously, others see it as a promising advancement for the 
					future.
					 
					
					The 
					researchers concluded:
					
						
						"This 
						finding warns that CRISPR technology must be further 
						tailored, particularly before it is used for human 
						
						gene 
						therapy."